BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 1881021)

  • 1. Anticoagulants in heart disease.
    Vine DL
    Kans Med; 1991 Apr; 92(4):114, 112. PubMed ID: 1881021
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for atrial fibrillation.
    Douglas M; Strelnick A
    J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial fibrillation and anticoagulation.
    Maxim R
    Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of thromboembolism in heart infarct, cardiomyopathy and atrial fibrillation].
    Straub PW
    Schweiz Med Wochenschr; 1990 Mar; 120(11):365-71. PubMed ID: 2181642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
    Darius H; Erbel R; Belz GG; Meyer J
    Internist (Berl); 1992 Oct; 33(10):670-83. PubMed ID: 1428685
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current status of antithrombotic therapy].
    Lengfelder W
    Dtsch Med Wochenschr; 1995 Jan; 120(4):105-10. PubMed ID: 7835235
    [No Abstract]   [Full Text] [Related]  

  • 10. [What anticoagulant therapy should be used for what form of atrial fibrillation?].
    Frantz E
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peri-operative anticoagulant therapy--the case for an uninterrupted dose-adjusted warfarin regimen in the high-risk patient.
    Franz RC
    S Afr J Surg; 2006 Aug; 44(3):84, 86. PubMed ID: 16958233
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peculiarities of antithrombotic treatment in exacerbation of coronary heart disease and transcutaneous coronary interventions in patients suffering from atrial fibrillation and taking vitamin K antagonists (literature review)].
    Iavelov IS
    Angiol Sosud Khir; 2010; 16(2):13-22. PubMed ID: 21032868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 16. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 17. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do not stop the warfarin until ..
    Cakulev I; Waldo AL
    J Am Coll Cardiol; 2010 Feb; 55(8):744-6. PubMed ID: 20170811
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian, Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5.
    Mant MJ
    Can J Cardiol; 1998 May; 14(5):663; author reply 663, 665. PubMed ID: 9627519
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.